DP
SRGA

Dearborn Partners’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Dearborn Partners’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,666
Closed -$26.7K – 252
2023
Q1 		$26.7K Hold
16,666
– – ﹤0.01% 240
2022
Q4 		$33.2K Hold
16,666
– – ﹤0.01% 244
2022
Q3 		$58K Hold
16,666
– – ﹤0.01% 255
2022
Q2 		$57K Buy
+16,666
New +$91.9K ﹤0.01% 254

Other funds holding SRGA

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Dearborn Partners's SRGA Position: Q2 2023 in Review

Dearborn Partners sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 16,666 shares — an estimated $26.7K sold.

Dearborn Partners first reported a position in SRGA in Q2 2022 and held it in 4 quarters. The position peaked at $58K in Q3 2022. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

  • Dearborn Partners reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dearborn Partners sold 16,666 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $26.7K.
  • Dearborn Partners first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Dearborn Partners's Surgalign Holdings, Inc. Common Stock position peaked at $58K in Q3 2022.
  • 25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Dearborn Partners's 13F filing for Q2 2023, filed 3 Aug 2023.